ShahroozEshaghianMDFACP
Oncology • Los Angeles, CACancer Genetics/Cancer Risk Assessment, Genitourinary Oncology, Hematologic Oncology
Physician
Dr. Eshaghian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2080 Century Park E
Ste 1005
Los Angeles, CA 90067Phone+1 310-229-3535Fax+1 310-229-3554
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
Cedars-Sinai Medical CenterResidency, Internal Medicine, 2006 - 2009
Albert Einstein College of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2007 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor 2013-2014
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013
Clinical Trials
- Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma Start of enrollment: 2012 Feb 01
- Safety, Efficacy, and Pharmacodynamics of a 60-Minute Infusion of Carfilzomib for Progressive Multiple Myeloma Start of enrollment: 2013 Apr 01
Publications & Presentations
PubMed
- A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.James R Berenson, Andrea Limon, Stephanie Rice, Tahmineh Safaie, Ralph Boccia
Targeted Oncology. 2024-05-01 - 2 citationsClinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients.Scott Jew, Sean Bujarski, Bernard Regidor, Marsiye Emamy-Sadr, Regina Swift
Targeted Oncology. 2023-09-01 - 2 citationsLoss of anti-spike antibodies following mRNA vaccination for COVID-19 among patients with multiple myeloma.Samuel D Stampfer, Sean Bujarski, Marissa-Skye Goldwater, Scott Jew, Bernard Regidor
Cancer Reports. 2023-05-01
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Farsi, Hebrew, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
